US Stock MarketDetailed Quotes

CRBP Corbus Pharmaceuticals

Watchlist
  • 17.8200
  • +0.1800+1.02%
Close Nov 29 13:00 ET
  • 18.1500
  • +0.3300+1.85%
Post 16:08 ET
217.04MMarket Cap-3783P/E (TTM)

Corbus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corbus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Corbus Pharmaceuticals Earnings Reports

  • Corbus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7 17:08 ET

  • Corbus Pharmaceuticals | 8-K: Corbus Pharmaceuticals Reports 3 rd Quarter 2024 Financial Results and Provides a Corporate Update

    Nov 7 08:43 ET

  • Corbus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:44 ET

  • Corbus Pharmaceuticals | 8-K: Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

    Aug 6 08:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 29, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data